Predictors for remission in rheumatoid arthritis patients: A systematic review.
about
Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs TreatmentImpact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational studyEarly increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritisThe number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineCirculating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study.Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis.Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumabPredictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritisLow serum levels of myeloid progenitor inhibitory factor-1 predict good response to methotrexate in rheumatoid arthritisThe problem of choice: current biologic agents and future prospects in RA.The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review.Remission in rheumatoid arthritis: is it all the same?Selected cytokine pathways in rheumatoid arthritis.Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.Effects of different medical treatments on serum copper, selenium and zinc levels in patients with rheumatoid arthritis.Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers.Guidelines for the drug treatment of rheumatoid arthritis.A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers.Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.Smoking cessation advice by rheumatologists: results of an international survey.Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.An immunological biomarker to predict MTX response in early RA.Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.
P2860
Q28551709-600C294C-CBC0-4F4C-B9CF-E35351C04225Q30727631-E5DE76F1-6F6F-4E19-9457-5AA87066C67FQ30863740-830865E5-B96A-4155-9922-233581C98BDEQ33781115-5FE941BF-F23E-4C17-9BD4-14A6DEFB637FQ33984823-D4635900-8A21-4591-9963-A9DA8D8C011CQ34894822-FE841E93-A1CE-4506-BF4D-E697928A0A6BQ35025598-4428B962-EDF8-4E2A-9F36-5246B4AA850FQ35557430-FF6AB88E-9F86-4ED4-BB49-51807D81B844Q35645491-983097B7-8DE8-473B-AA57-423E13436204Q35759047-485FE008-7E68-486B-9B34-67508955DC97Q35792901-29A70991-5D5E-4248-826C-91A33B03EA6EQ36028729-8BB02972-6986-46F5-835A-DA4E6D5A2028Q36098311-72CF6C82-2732-48E4-926A-5E6DB25CE0D6Q36104458-EAA94D71-B56D-40CF-B9E4-B4C57682E350Q36255424-10A30C79-F06C-4F98-A235-28DB8B885B7EQ36706945-42F9B844-59E3-44FC-BB06-CD2111417054Q36885296-B13EE10F-557D-4990-85EE-F772D0801F35Q37118948-1F04256C-81B8-4DFC-B922-453198DC3A96Q37195347-A241DF55-C24F-4DD1-B9A0-C3547140E8FCQ37356217-C74AA4B0-AA4A-4DCF-BFF7-B3BFBA001B02Q37456872-9223F253-C212-4676-8AED-E1E6FE0706B7Q38082588-067B40E4-472E-4A0E-BA7C-5B86705C3E34Q38357969-F737F74E-ED2C-4C3A-BC39-B89C9666458AQ38541414-6237FDAB-A9C5-4AEE-8DD9-70531D18B96CQ38755912-C3318468-7439-46EE-ABC9-1A72FD5201DAQ38804610-BC8D82DF-8B1F-42B3-B934-8E106930A404Q38847005-264B560B-0CAA-4966-AFF1-F72E35B18D84Q38937827-5572C493-7820-4D50-9B06-483543E83465Q38958301-DEF190D2-AA2B-42CF-97DD-80A1394BD81CQ40275215-84A6087F-3B9C-4D47-A37E-F61B4C8A2639Q41935154-05D1623C-A5F7-41E1-B2DC-C9E41D2C6C08Q42057681-91992391-8D31-49E8-B795-A33D0401C8ADQ43613356-C9A921BA-2504-464F-97AE-4BB8F17B2787Q43675571-857021BD-6558-49C2-94A6-4AF3DDC474F5Q43686385-B7B08B88-174D-455A-8C3F-2BEFC6F1AD0DQ44621683-B68B3209-FAA5-436C-AF5B-B3C3AF9C4659Q45393589-759B7FD0-3036-4120-B931-B50B83FEB706Q45713588-3D01EB93-6877-47E3-B0F6-AFC1A107A4B7Q45830734-7330C210-5A19-446F-84F7-3E900F73C7B4Q47623088-CCD10E19-55CF-44EF-AD52-25C9CE7FB45D
P2860
Predictors for remission in rheumatoid arthritis patients: A systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@en
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@nl
type
label
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@en
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@nl
prefLabel
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@en
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@nl
P2093
P356
P1476
Predictors for remission in rheumatoid arthritis patients: A systematic review.
@en
P2093
Carine Salliot
Claire Bombardier
Hsing-Ju Lucy Lin
Sindhu Johnson
Veerapong Phumethum
Wanruchada Katchamart
P304
P356
10.1002/ACR.20188
P577
2010-08-01T00:00:00Z